Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine

(2018) Leif Carlsson et al.   Molecular Therapy-Methods & Clinical Development

Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing

(2018) Naidi Sun et al.   Scientific Reports

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

(2017) Kapil Bahl et al.   MOLECULAR THERAPY

Synthetic Chemically Modified mRNA (modRNA): Toward a New Technology Platform for Cardiovascular Biology and Medicine

(2014) K. R. Chien et al.   Cold Spring Harbor Perspectives in Medicine

Cardiovascular gene therapy with vascular endothelial growth factors

(2013) Seppo Ylä-Herttuala   GENE

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

(2013) Lior Zangi et al.   NATURE BIOTECHNOLOGY

VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond

(2012) M Giacca et al.   GENE THERAPY

Human Studies of Angiogenic Gene Therapy

(2009) Rajesh Gupta et al.   CIRCULATION RESEARCH

The diabetic foot: grand overview, epidemiology and pathogenesis

(2008) Andrew J. M. Boulton   DIABETES-METABOLISM RESEARCH AND REVIEWS